The differences in faecal bacterial population between irritable bowel syndrome (IBS) and control subjects have been reported in several studies. The aim of the present study was to compare the predominant and clostridial faecal microbiota of IBS subjects and healthy controls by applying denaturing gradient gel electrophoresis (DGGE) and a recently developed multiplexed and quantitative hybridization-based technique, transcript analysis with the aid of affinity capture (TRAC). According to the results, the studied clostridial groups (Clostridium histolyticum, Clostridium coccoides-Eubacterium rectale, Clostridium lituseburense and Clostridium leptum) represented the dominant faecal microbiota of most of the studied subjects, comprising altogether 29-87 % of the total bacteria as determined by the hybridized 16S rRNA. The C. coccoides-E. rectale group was the dominant subgroup of clostridia, contributing a mean of 43 % of the total bacteria in control subjects and 30 % (constipation type) to 50 % (diarrhoea type) in different IBS symptom category subjects. The proportion of the C. coccoides-E. rectale group was found to be significantly lower in the constipation-type IBS subjects than in the control subjects. DNA-based PCR-DGGE and RNA-based RT-PCR-DGGE analyses targeted to the predominant bacterial population showed considerable biodiversity as well as uniqueness of the microbiota in each subject, in both control and IBS subject groups. The RT-PCR-DGGE profiles of the IBS subjects further indicated higher instability of the bacterial population compared to the control subjects. The observations suggest that clostridial microbiota, in addition to the instability of the active predominant faecal bacterial population, may be involved in IBS.
INTRODUCTIONThe composition of the resident intestinal microbiota varies between individuals, and the predominant population is fairly stable under normal conditions (Zoetendal et al., 1998; Harmsen et al., 2002a;Vanhoutte et al., 2004; Mättö et al., 2005). However, several factors, such as antibiotic therapy, ageing and disease, may cause disturbances in the intestinal balance. Transient disturbance of the intestinal microbiota during antibiotic therapy has been shown in several studies (Edlund & Nord, 2000; Donskey et al., 2003). Changes in the intestinal microbiota have also been suggested to occur in certain intestinal diseases and disorders, such as inflammatory bowel disease (IBD) (Seksik et al., 2003) and irritable bowel syndrome (IBS) (Madden & Hunter, 2002). IBS is an intestinal disorder that involves continuous or recurrent intestinal pain or discomfort that is relieved during defecation. In addition, IBS symptoms include bloating, altered stool frequency, form or passage, and passage of mucus (Thompson et al., 1999). The existence of abnormal colonic fermentation in IBS (King et al., 1998) and alleviation of IBS symptoms by eradication of small intestinal bacterial overgrowth by antibiotic therapy (Pimentel et al., 2000), suggest that the intestinal microbiota has...